Yinxing Yedi Ji (银杏叶滴剂)银杏叶滴剂
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 山东仙河药业有限公司Chinese legal name: 山东仙河药业有限公司
主要成分Active Ingredients
- 银杏叶提取物滴Yinxing Yeti Quwu Di
药物知识说明
银杏叶提取物滴是一种在国家药监局注册认定的药品。标注生产企业为山东仙河药业有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：山东仙河药业有限公司Chinese legal name: 山东仙河药业有限公司、山东仙河药业有限公司Chinese legal name: 山东仙河药业有限公司、山东仙河药业有限公司Chinese legal name: 山东仙河药业有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 银杏叶滴剂) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 山东仙河药业有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 山东仙河药业有限公司Chinese legal name: 山东仙河药业有限公司, 山东仙河药业有限公司Chinese legal name: 山东仙河药业有限公司, 山东仙河药业有限公司Chinese legal name: 山东仙河药业有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 银杏叶滴剂Recorded Chinese name: 银杏叶滴剂
- 规格Specification: 每瓶10ml（相当于银杏叶提取物400mg）Recorded Chinese specification: 每瓶10ml（相当于银杏叶提取物400mg）
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 山东仙河药业有限公司Chinese legal name: 山东仙河药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z20080674
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z20080674
Manufacturer
Chinese legal name: 山东仙河药业有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字Z20080674
生产企业
山东仙河药业有限公司(国产)
功能主治
具有活血化瘀通络之功能，用于瘀血阻络引起的胸痹、心痛、中风、半身不遂、舌强语蹇；冠心病稳定型心绞痛、脑梗塞见上述征候者。
用法用量
口服，一日2-3次，一次1-2毫升，(20滴/ml)，可滴入少许温水中服用。
不良反应
罕有胃肠道不适、头痛、过敏反应等现象发生，一般不需要特殊处理即可自行解。
禁忌
对本品过敏者禁用。
注意事项
1.心力衰竭者,孕妇及过敏体质者慎用。
2.药品性状发生改变时禁止使用。
3.请将此药品放在儿童不能接触的地方。
4.本品耐受性良好，罕有胃肠道不适、头痛、过敏反应等现象发生，一般不需要特殊处理即可自行解。
贮藏
密封，阴凉处
规格
每瓶10ml（相当于银杏叶提取物400mg）
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.